Cite
New Neuroendocrine Cancer Findings Reported from Molecular Immunology Unit (Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-beta)
MLA
“New Neuroendocrine Cancer Findings Reported from Molecular Immunology Unit (Imatinib Spares CKit-Expressing Prostate Neuroendocrine Tumors, Whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-Beta).” Obesity, Fitness & Wellness Week, Apr. 2017, p. 6972. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.488903803&authtype=sso&custid=ns315887.
APA
New Neuroendocrine Cancer Findings Reported from Molecular Immunology Unit (Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-beta). (2017, April 15). Obesity, Fitness & Wellness Week, 6972.
Chicago
Obesity, Fitness & Wellness Week. 2017. “New Neuroendocrine Cancer Findings Reported from Molecular Immunology Unit (Imatinib Spares CKit-Expressing Prostate Neuroendocrine Tumors, Whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-Beta),” April 15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.488903803&authtype=sso&custid=ns315887.